Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 303,992 | 153,082 | 323,333 | 176,134 | 64,946 |
| Cost of Goods | 143,121 | 68,892 | 79,576 | 88,724 | 28,055 |
| Gross Profit | 160,871 | 84,190 | 243,757 | 87,410 | 36,891 |
| Operating Expenses | 37,632 | 35,788 | 33,354 | 36,005 | 26,783 |
| Operating Income | 123,360 | 49,294 | 210,979 | 52,129 | 10,163 |
| Interest Expense | 38 | 23 | 46 | -490 | 185 |
| Other Income | 314 | 167 | 64 | 121 | 174 |
| Pre-tax Income | 123,636 | 49,438 | 210,997 | 52,740 | 10,152 |
| Income Tax | 48,501 | 18,130 | 79,484 | 14,633 | 3,495 |
| Net Income Continuous | 75,135 | 31,308 | 131,513 | 38,107 | 6,657 |
| Minority Interests | -28 | -40 | 28 | -37 | -28 |
| Net Income | $75,163 | $31,348 | $131,485 | $38,144 | $6,685 |
| EPS Basic Total Ops | 1.20 | 0.51 | 2.16 | 0.63 | 0.11 |
| EPS Basic Continuous Ops | 1.20 | 0.51 | 2.16 | 0.63 | 0.11 |
| EPS Diluted Total Ops | 1.15 | 0.48 | 2.06 | 0.61 | 0.11 |
| EPS Diluted Continuous Ops | 1.15 | 0.48 | 2.06 | 0.61 | 0.11 |
| EBITDA(a) | $223,679 | $57,592 | $218,199 | $50,367 | $28,668 |